{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:07:45Z","timestamp":1750284465045,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1124\/jpet.122.001570","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:40:13Z","timestamp":1694551213000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception"],"prefix":"10.1016","volume":"389","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-8176","authenticated-orcid":false,"given":"Sarah L.","family":"Withey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Paronis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001570_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy [published correction appears in Ann Intern Med (2006) 144: 460]","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.122.001570_bib2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4088\/JCP.09m05080ecr","article-title":"Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment","volume":"71","author":"Brooks","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.122.001570_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s002130000453","article-title":"Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the \u03bc opioid receptor","volume":"150","author":"Cook","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001570_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00433012","article-title":"Drug reinstatement of heroin-reinforced responding in the rat","volume":"79","author":"de Wit","year":"1983","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001570_bib5","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/pm\/pnw010","article-title":"Changes in pain sensitivity and pain modulation during oral opioid treatment: the impact of negative affect","volume":"17","author":"Edwards","year":"2016","journal-title":"Pain Med"},{"key":"10.1124\/jpet.122.001570_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0022-3565(25)23877-0","article-title":"Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys","volume":"271","author":"Gerak","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001570_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s005400170004","article-title":"Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine","volume":"15","author":"Gringauz","year":"2001","journal-title":"J Anesth"},{"key":"10.1124\/jpet.122.001570_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/1097-0142(19910901)68:5<1121::AID-CNCR2820680539>3.0.CO;2-1","article-title":"Pain management in the opioid-addicted patient with cancer","volume":"68","author":"Hoffman","year":"1991","journal-title":"Cancer"},{"key":"10.1124\/jpet.122.001570_bib9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001570_bib10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.drugalcdep.2013.04.021","article-title":"Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia","volume":"132","author":"Krupitsky","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001570_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"key":"10.1124\/jpet.122.001570_bib12","series-title":"An Evidence-Based Resource for Pain Relief","first-page":"78","author":"McQuay","year":"1998"},{"key":"10.1124\/jpet.122.001570_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0022-3565(24)38224-2","article-title":"Sensitivity to the discriminative stimulus and antinociceptive effects of \u03bc opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the \u03bc opioid receptor","volume":"289","author":"Morgan","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001570_bib14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1476-5381.2011.01335.x","article-title":"Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human","volume":"164","author":"Morgan","year":"2011","journal-title":"Br J Pharmacol"},{"year":"2011","series-title":"Guide for the Care and Use of Laboratory Animals","key":"10.1124\/jpet.122.001570_bib80"},{"key":"10.1124\/jpet.122.001570_bib15","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0022-3565(25)21270-8","article-title":"Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by mu, kappa and delta opioid agonists","volume":"279","author":"Picker","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001570_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002280050386","article-title":"Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflex","volume":"53","author":"Piguet","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.122.001570_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0921s32","article-title":"Intravenous self-administration techniques in monkeys","author":"Platt","year":"2005","journal-title":"Curr Protoc Neurosci"},{"key":"10.1124\/jpet.122.001570_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(24)37557-3","article-title":"Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone","volume":"286","author":"Rowlett","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001570_bib19","first-page":"412","article-title":"Treatment of pain in methadone-maintained patients","volume":"67","author":"Scimeca","year":"2000","journal-title":"Mt Sinai J Med"},{"key":"10.1124\/jpet.122.001570_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.drugalcdep.2007.06.013","article-title":"Management of relapse in naltrexone maintenance for heroin dependence","volume":"91","author":"Sullivan","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.122.001570_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/bmj.332.7534.132","article-title":"Naltrexone and problems in pain management","volume":"332","author":"Vickers","year":"2006","journal-title":"BMJ"},{"key":"10.1124\/jpet.122.001570_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3565(25)39450-4","article-title":"Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine","volume":"267","author":"Walker","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001570_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1124\/jpet.103.058503","article-title":"Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline","volume":"310","author":"Walker","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001570_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s002130050366","article-title":"Tolerance and cross-tolerance to morphine-like stimulus effects of \u03bc opioids in rats","volume":"133","author":"Walker","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.122.001570_bib25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-3565(25)09651-X","article-title":"Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure","volume":"273","author":"Walker","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001570_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jpain.2018.02.003","article-title":"Concurrent assessment of the antinociceptive and behaviorally disruptive effects of opioids in squirrel monkeys","volume":"19","author":"Withey","year":"2018","journal-title":"J Pain"},{"key":"10.1124\/jpet.122.001570_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1124\/jpet.119.259010","article-title":"Behavioral effects of opioid full and partial agonists during chronic buprenorphine treatment","volume":"371","author":"Withey","year":"2019","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524172199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524172199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:17:53Z","timestamp":1739978273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524172199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0022356524172199"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001570","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}